Home
About Us
Subject
Browse
0
Sign In
Pituitary Tumors II
MON-303 Giant Growth Hormone Secreting Pituitary Adenomas: A Single Institution Case Series
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-318 Acute, Life-Threatening and Perioperative Complications in Cushing’s Syndrome: Predictors and Outcomes
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-310 Factors Associated with Remission After Surgery for Acromegaly
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-LB46 Thyrotropinoma and Pregnancy
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-299 Risk Factors of Re-Growth of Non-Functional Pituitary Adenomas
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-323 IGF-I Variability and Its Association with Demographic and Clinical Characteristics in Patients with Acromegaly Treated with Injectable Somatostatin Receptor Ligands (SRLS); Results from an International Prospective Phase III Study
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-LB49 Atypical Presentation for a 5.5-cm Macroprolactinoma: Unilateral Visual Loss and Only Partial Hypopituitarism; Asymptomatic Hypogonadism
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-297 Withdrawal from Long-Acting Somatostatin Receptor Ligand Injections in Adult Patients with Acromegaly: Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-321 AgRP and Food Cravings Decrease with Treatment of Cushing’s Disease
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-317 Prognostic Factors and Mortality According to the Structural and Functional Classification of Acromegaly
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-326 Non Functioning Pituitary Adenomas (NFPA): Sex Related Differences in Presentation, Clinical Features and Outcomes
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-328 Disorders of Glucose Metabolism in Cushing Syndrome in Uzbekistan
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-300 AIP Gene Germline Mutations in Non-Selected Patients with Apparently Sporadic Pituitary Macrodenomas
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-314 Analysis of Adverse Events in Adult Patients with Acromegaly Receiving Oral Octreotide Capsules: Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-332 Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing’s Syndrome (LOGICS): A Double-Blind, Placebo-Controlled, Withdrawal Study
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
MON-306 Acromegaly Comorbidity Costs, Quality of Life, and Mortality: Lifetime Comparisons for Controlled Acromegaly, Uncontrolled Acromegaly, and the General US Population
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Load More
More Info